CASE STUDY: METHODOLOGY IN BUILDING INFORMATION AND EDUCATION RESOURCES FOR A NATIONAL SCREENING PROGRAM Supporting participation paramount in the upcoming National Lung Cancer Screening Program
With
Dr Rachael Dodd
Senior Research Fellow,
The Daffodil Centre, a Cancer Council NSW & The University of Sydney Joint Venture
AUSTRALIAN HEALTH JOURNAL CASE STUDY
Filmed in Sydney | April 2025
At the recent Screening Conference 2025 in Sydney, hosted by Public Health Association, Dr Rachael Dodd, Senior Research Fellow at The Daffodil Centre, spoke about the information and educational resources created to increase awareness in the healthcare workforce and community on the upcoming Australia’s National Lung Cancer Screening Program commencing in July 2025.
A consortium including The Daffodil Centre, Lung Foundation Australia, Cancer Council Victoria and University of Melbourne were engaged by the Australian Government, through Cancer Australia to deliver a suite of information materials, workforce education resources, and a dissemination strategy for the Program, seen as paramount to support participation.
Dr Dodd talked to Australian Health Journal about the qualitative research process over the past 6 years, from a scoping review of existing lung cancer screening (LCS) information materials and messaging and an environmental scan of existing cancer screening program resources to inform initial development of the key messages, proposed information resources and the dissemination strategy. These were further developed through individual interviews and co-design workshops with the healthcare workforce and community members.
The scoping review identified 34 articles reporting strategies to increase awareness and knowledge of LCS. The environmental scan found 13 provider-focused resources and 18 consumer-focused resources across Australian screening programs. Most LCS-specific resources (18 sets) were from the United States, United Kingdom, Canada and Singapore.
Key ideas arising from the consultations (28 community; 35 health workforce) and co-design workshops (2 health workforce (n=41), 1 community (n=18)) were the need for: clear information about eligibility criteria, a pack-year smoking calculator, easy-to-read detail about the National Cancer Screening Register, examples of symptoms of lung cancer, clarity on referral pathways, a centralised website to host resources, videos of the screening process, guidance for ineligible participants, and managing conversations including smoking behaviours, and lung cancer stigma. Digital resources were generally preferred to paper resources.
Source: Adapted from Screening Conference 2025 Abstract Book
-
Understanding extracellular vesicles in cancer therapy research
Joy Wolfram is an Associate Professor at the Australian Institute for Bioengineering and Nanotechnology and the School of Chemical Engineering at the University of Queensland in Australia. Originally from Finland, she earned both her bachelor’s and master’s degrees in biology before transitioning to engineering with a PhD in nanotechnology completed in China. Wolfram has over a decade of experience working in hospitals in the United States before joining the University of Queensland.
Her research focuses on extracellular vesicles, which are crucial for cell communication both locally within tissues and over longer distances between organs. Her lab studies the roles of these vesicles in both health and disease, particularly in cancer. They investigate the harmful messages released by cancer cells that aid in tumour growth, specifically in breast cancer, while also exploring how to harness beneficial extracellular vesicles from healthy individuals as potential therapeutics.
-
Bionic eye trial shows improvements in functional vision for retinitis pigmentosa
Results of the first clinical trial of Australia’s ‘second generation’ bionic eye have demonstrated ‘substantial improvement’ in four participants’ functional vision, daily activities and quality of life over a period of more than two and a half years.
Led by the Centre for Eye Research Australia, Bionics Institute, University of Melbourne and Royal Victorian Eye and Ear Hospital, the trial findings add to interim results which showed that the second-generation bionic eye developed by Australian company Bionic Vision Technologies provided rapid improvements for four patients with blindness caused the genetic eye condition retinitis pigmentosa.
-
Spinal implant technology eyes global opportunity
Adelaide, South Australia wants to let the secret out, and be known as hub for medical devices, pharmaceuticals, biotechnology, and digital health. It boasts world-class research institutions, such as the University of Adelaide and SAHMRI, fostering innovation and collaboration. The city’s supportive government policies provide incentives, grants, and streamlined regulations for businesses. Adelaide’s skilled workforce, renowned for its expertise in health sciences, offers a talent pool to drive industry growth. Additionally, the city’s strategic location, advanced infrastructure, and strong healthcare ecosystem make it an ideal base for development, manufacturing, and market access, attracting companies in these sectors.
